Lewin M, Arrivé L, Lacombe C, Vignaud A, Azizi L, Raynal M, Jomaah N, Monnier-Cholley L, Tubiana Jm, Menu Y
Service de Radiologie, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, 184, rue du Faubourg Saint-Antoine, 75571 Paris cedex 12, France.
J Radiol. 2010 Jan;91(1 Pt 1):11-26. doi: 10.1016/s0221-0363(10)70002-0.
Due to ongoing technological advances, the range of clinical applications for diffusion-weighted MR imaging has expanded to now include abdominal pathology. Current applications for liver pathology include two main directions. First, oncologic imaging with detection, characterization and follow-up of lesions. Second, evaluation of diffuse liver diseases, including hepatic fibrosis. The diagnostic impact and role of diffusion-weighted MR imaging remain under investigation, but appear promising. Because of its short acquisition time, sensitivity, and additional information it provides, diffusion-weighted MR imaging should be included in routine liver imaging protocols.
由于不断的技术进步,扩散加权磁共振成像的临床应用范围现已扩大到包括腹部病理学。目前肝脏病理学的应用包括两个主要方向。第一,肿瘤成像,用于病变的检测、特征描述和随访。第二,评估弥漫性肝病,包括肝纤维化。扩散加权磁共振成像的诊断影响和作用仍在研究中,但前景似乎乐观。由于其采集时间短、灵敏度高以及能提供额外信息,扩散加权磁共振成像应纳入常规肝脏成像方案。